Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had revenue of $442.59M in the twelve months ending March 31, 2024, with 15.29% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $108.83M with 8.30% year-over-year growth. In the year 2023, Ultragenyx Pharmaceutical had annual revenue of $434.25M with 19.52% growth.

• Revenue (ttm): $442.59M
• Revenue Growth: +15.29%
• P/S Ratio: 7.95
• Revenue / Employee: $346,854
• Employees: 1,276
• Market Cap: 3.52B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	434.25M	70.92M	19.52%
Dec 31, 2022	363.33M	11.92M	3.39%
Dec 31, 2021	351.41M	80.38M	29.66%
Dec 31, 2020	271.03M	167.32M	161.32%
Dec 31, 2019	103.71M	52.22M	101.41%
Dec 31, 2018	51.50M	48.88M	1,871.48%
Dec 31, 2017	2.61M	2.48M	1,863.91%
Dec 31, 2016	133.00K	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.